-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Milestone Pharmaceuticals, Lowers Price Target to $10

Benzinga·04/01/2025 16:34:44
Listen to the news
HC Wainwright & Co. analyst Patrick Trucchio maintains Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and lowers the price target from $25 to $10.